MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000513067

Медицинская библиотека · Digestive diseases (Basel, Switzerland) · 2020

Does Perianal Disease Influence the Efficacy of Combination Therapy in Crohn's Disease?

de Sousa Magalhães Rui, Xavier Sofia, Cúrdia Gonçalves Tiago, Dias de Castro Francisca, Rosa Bruno, Moreira Maria João, Cotter José

Оценочное исследованиеСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Perianal disease is associated with a disabling course of Crohn's disease (CD). We aim to study the impact of perianal disease on CD remission rates, after a 1-year course of infliximab in combination therapy with azathioprine.

METHODS

This was a retrospective, single-center cohort study, including consecutive CD patients on combination therapy, followed for 1 year since induction. The outcome variable was split into clinical and endoscopic remissions. The correlation toward the outcome variable was assessed with univariate and multivariate analysis and a survival assessment, using SPSS software.

RESULTS

We assessed 74 CD patients, of whom 41 (55.4%) were female, with a mean age of 36 years. Thirty-nine percent of the patients presented perianal disease at diagnosis (n = 29). We documented 70.3% clinical and 47.2% endoscopic remissions. Several variables had statistical significance toward the outcomes (endoscopic and clinical remissions) in the univariate analysis. After adjusting for confoundment, patients with perianal disease presented an odds ratio (OR) of 0.201 for achieving endoscopic remission (CI: 0.054-0.75, p value 0.017) and an OR of 0.203 for achieving clinical remission (CI: 0.048-0.862, p value 0.031). Sixty-six patients (89.2%) presented an initial response to treatment, from whom, 20 (30.3%) exhibited at least 1 disease relapse (clinical and/or endoscopic). Patients with perianal disease presented higher probability of disease relapse, displaying statistically significant difference on Kaplan-Meier curves (Breslow p value 0.043).

CONCLUSION

In the first year of combination therapy, perianal disease is associated with an 80% decrease in endoscopic and clinical remission rates and higher ratio of disease relapse.

Для цитирования: de Sousa Magalhães Rui, Xavier Sofia, Cúrdia Gonçalves Tiago, Dias de Castro Francisca, Rosa Bruno, Moreira Maria João, Cotter José. Does Perianal Disease Influence the Efficacy of Combination Therapy in Crohn's Disease?. Digestive diseases (Basel, Switzerland). 2020. DOI: 10.1159/000513067.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.